Patents by Inventor Mark V. Silva

Mark V. Silva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted heterocyclic ethers and their use in CNS disorders
    Patent number: 8071778
    Abstract: The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders.
    Type: Grant
    Filed: January 25, 2008
    Date of Patent: December 6, 2011
    Assignee: Bristol-Myers Squibb Company
    Inventors: Michael F. Parker, Joanne J. Bronson, Mark V. Silva, Kevin W. Gillman
  • Substituted Heterocyclic Ethers and Their Use in CNS Disorders
    Publication number: 20090030040
    Abstract: The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders.
    Type: Application
    Filed: January 25, 2008
    Publication date: January 29, 2009
    Inventors: Michael F. Parker, Joanne J. Bronson, Mark V. Silva, Kevin W. Gillman
  • SUBSTITUTED HETEROCYCLIC ETHERS AND THEIR USE IN CNS DISORDERS
    Publication number: 20080027056
    Abstract: The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders.
    Type: Application
    Filed: July 24, 2007
    Publication date: January 31, 2008
    Inventors: Michael F. Parker, Joanne J. Bronson, Mark V. Silva, Kevin W. Gillman